Senior Vice President, Commercial

Ocular Therapeutix™ to Participate in Upcoming Scientific Conferences

Ocular Therapeutix price target raised by $10 at Piper Sandler, here's why

Ocular Therapeutix price target raised by $7 at Baird, here's why

Transcript : Ocular Therapeutix, Inc. - Analyst/Investor Day

Senior Director, Clinical Development

Ocular Therapeutix, Inc. is a biopharmaceutical company focused on innovative therapies for eye diseases. The Senior Director, Clinical Development will oversee the design and execution of clinical studies, ensuring compliance with regulatory standards and guiding cross-functional teams in clinical research activities.

Sign up with Google

Sign in with Google